The public perception of mental health and violent behaviour has often been influenced by poor media coverage and a focus on specific crimes committed by people with psychosis. There’s a nice summary of work in this area on the Mind website, which includes a number of enlightening stats, including this one: The fear of random [read the full story…]
Alzheimer’s disease affects 1-2% of people aged 65-70 and approximately 20% of those over 80 years. As our population ages, the condition is on the increase and it’s estimated that 2030, an estimated 7.7 million Americans aged 65 and older will have Alzheimer’s disease. We do not yet know exactly how and why Alzheimer’s disease [read the full story…]
People with depression frequently have trouble sleeping and this restlessness often first appears at the onset of the depressive disorder and continues until well after the depression has been successfully treated. This new meta-analysis conducted by a research team from the University of Freiburg Medical Center in Germany, investigates if insomnia can be viewed as [read the full story…]
Mental Elf readers have been voting for their favourite topics and top of the list at present are psychological therapies and depression. Us elves like to give people what they want, so here’s a review conducted by researchers in the Netherlands that summarises what we know about the effectiveness of different types of psychotherapy in [read the full story…]
Cannabis (marijuana) is the most widely used illicit drug in the world and reports of driving under the influence of cannabis have risen in recent years. A research team from Dalhousie University in Canada conducted a systematic search and identified observational epidemiology studies of motor vehicle collisions with an appropriate control group. They included studies [read the full story…]
This new systematic review compares how effective first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) are at preventing relapse in patients with schizophrenia. The authors carried out a meta-analysis of 23 randomised controlled trials that lasted for ≥6 months and compared FGAs with SGAs in schizophrenia. The outcomes they studied were: Study defined relapse Relapse at 3, [read the full story…]
In 2004 the US Food and Drug Administration published a “black box” warning that highlighted an increased risk of suicide and suicidal thoughts in young people who were taking antidepressants. This warning was updated in 2007. A new analysis of 41 randomised controlled trials has been published in the Archives of General Psychiatry, which suggests [read the full story…]
We have learnt so much about mental illness in the last few decades and the science behind diagnosing, managing and supporting people with individual conditions has improved dramatically. Despite this improved knowledge, public attitudes to mental health issues remain varied and we still frequently hear horror stories about how people with mental health conditions are [read the full story…]
There is a growing pool of research that looks into the impact that exercise can have on depression, but this systematic review and meta-analysis claims to be the first summary of trials into the effects of exercise training on depressive symptoms among patients with a chronic illness. The research team from the University of Alabama [read the full story…]
Campaigns in the media that encourage people not to take illicit drugs are now commonplace in the US, but a systematic review of the effectiveness of these interventions has not been conducted until now. A team of researchers from Vancouver in Canada have carried out a systematic review and meta-analysis of 7 randomised controlled trials [read the full story…]
